Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings

Cancer Science

Volumn 100, Issue 11, 2009, Pages 2175-2180

  Wang, Kai Hung ^a,b   Liu, Hwan Wun ^c,d   Lin, Shih Rung ^a,b   Ding, Da Ching ^a,c   Chu, Tang Yuan ^a,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b Graduate Institute of Medical Science   (Taiwan)

^c Graduate Institute of Clinical Medicine   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; PROTOCADHERIN 10; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DEMETHYLATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; GENE SILENCING; HELA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; AGED; CADHERINS; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE SILENCING; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 71049140477     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01285.x     Document Type: Article

References (28)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-44.
2. Walboomers JM, Jacobs MV, Manos MM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression?. Oncogene 2008, 27:6920-9.
4. Patel SD, Chen CP, Bahna F, Honig B, Shapiro L. Cadherin-mediated cell-cell adhesion: sticking together as a family. Curr Opin Struct Biol 2003, 13:690-8.
5. Wheelock MJ, Johnson KR. Cadherin-mediated cellular signaling. Curr Opin Cell Biol 2003, 15:509-14.
6. Duenas-Gonzalez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 2005, 4:38.
7. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-28.
8. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001, 1:157-62.
9. Stemmler MP. Cadherins in development and cancer. Mol Biosyst 2008, 4:835-50.
10. Wolverton T, Lalande M. Identification and characterization of three members of a novel subclass of protocadherins. Genomics 2001, 76:66-72.
11. Uemura M, Nakao S, Suzuki ST, Takeichi M, Hirano S. OL-Protocadherin is essential for growth of striatal axons and thalamocortical projections. Nat Neurosci 2007, 10:1151-9.
12. Hammond C, Jeffers L, Carr BI, Simon D. Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma. Hepatology 1999, 29:1479-85.
13. Knosel T, Schluns K, Stein U. Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia 2004, 6:23-8.
14. Matsui S, LaDuca J, Rossi MR, Nowak NJ, Cowell JK. Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells. Cancer Genet Cytogenet 2005, 159:18-26.
15. Nowak NJ, Gaile D, Conroy JM. Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 2005, 161:36-50.
16. Price GR, Armes JE, Ramus SJ. Phenotype-directed analysis of genotype in early-onset, familial breast cancers. Pathology 2006, 38:520-7.
17. Ying J, Li H, Seng TJ. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006, 25:1070-80.
18. Miyamoto K, Fukutomi T, Akashi-Tanaka S. Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer 2005, 116:407-14.
19. Ying J, Gao Z, Li H. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. Br J Haematol 2007, 136:829-32.
20. Yu J, Cheng YY, Tao Q. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 2008, 136:640-51.
21. Pecoraro G, Lee M, Morgan D, Defendi V. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am J Pathol 1991, 138:1-8.
22. Huang SL, Chao A, Hsueh S. Comparison between the Hybrid Capture II Test and an SPF1/GP6 + PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol 2006, 44:1733-9.
23. Lin CY, Chen HC, Lin RW. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods 2007, 140:1-9.
24. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001, 3:289-93.
25. Paul R, Ewing CM, Jarrard DF, Isaacs WB. The cadherin cell-cell adhesion pathway in prostate cancer progression. Br J Urol 1997, 79(Suppl 1):37-43.
26. Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res 2008, 68:8616-25.
27. Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007, 17:3-14.
28. Kopfstein L, Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 2006, 63:449-68.